17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark
HSD17B1 may be a prognostic marker for recurrence and HSD17B2 may be predictive of response to tamoxifen therapy in breast cancer.
Authors
- Kristina Bang Christensen (ORCID: https://orcid.org/0000-0002-0008-7359)
- Lindsay Jane Collin (ORCID: https://orcid.org/0000-0003-0170-2592)
- Lauren E. McCullough (ORCID: https://orcid.org/0000-0001-6723-9540)
- Henrik Toft Sørensen (ORCID: https://orcid.org/0000-0003-4299-7040)
- Timothy L. Lash (ORCID: https://orcid.org/0000-0002-5240-5195)
- Peer Christiansen (ORCID: https://orcid.org/0000-0003-2748-9240)
- S. Hamilton-Dutoit
- Kristina Lystlund Lauridsen (ORCID: https://orcid.org/0000-0002-2415-9396)
- L. Waller
- Kirsten M. Woolpert (ORCID: https://orcid.org/0000-0002-5536-7649)
- Deirdre Cronin‐Fenton (ORCID: https://orcid.org/0000-0001-9738-2284)
- Thomas P. Ahern (ORCID: https://orcid.org/0000-0003-0440-8727)
- P. Damkier
- Anders Kjærsgaard (ORCID: https://orcid.org/0000-0001-9433-6442)
- Michael Goodman
- Bent Ejlertsen
Institutions
- University of Vermont (US)
- University of Copenhagen (DK)
- Emory University (US)
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Danish Breast Cancer Cooperative Group (DK)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1186/s13058-025-02196-2
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00